Foundry Partners, LLC - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
Foundry Partners, LLC ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$5,127,437
+7.0%
481,902
+5.8%
0.31%
+4.0%
Q1 2023$4,790,966
+89668.9%
455,415
+5.7%
0.30%
+2.7%
Q4 2022$5,337
-99.9%
430,775
+21.3%
0.29%
+26.7%
Q3 2022$3,678,000
+0.5%
355,050
+11.9%
0.23%
+5.5%
Q2 2022$3,658,000
+11.9%
317,226
+22.0%
0.22%
+31.7%
Q1 2022$3,270,000
-66.1%
259,943
-68.6%
0.17%
-51.2%
Q4 2021$9,651,000
-17.3%
827,733
-7.3%
0.34%
-18.4%
Q3 2021$11,663,000893,0700.42%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$188,977,00019.02%
13D Management LLC 600,431$6,923,0003.06%
BRIDGER MANAGEMENT, LLC 956,014$11,023,0002.48%
Brown Capital Management 11,641,935$134,232,0001.80%
Price Jennifer C. 520,000$5,996,0001.02%
Monarch Partners Asset Management LLC 272,425$3,141,0000.88%
ALPHASIMPLEX GROUP, LLC 10,510$121,0000.86%
Intrinsic Value Partners, LLC 54,105$624,0000.80%
CLARK ESTATES INC/NY 355,000$4,093,0000.71%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 692$60,000,0000.63%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders